Walleye Capital LLC Concert Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $323,538 - $435,360	74,548 New	74,548 $435,000
Q2 2022 Aug 08, 2022	BUY	$2.8 - $6.36 $558,600 - $1.27 Million	199,500 New	199,500 $840,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $219,012 - $286,719	-69,089 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $57,164 - $79,454	15,163 Added 28.12%	69,089 $292,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $262,080 - $704,812	53,926 New	53,926 $269,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.